Appili Therapeutics Inc. (APLI.TO)

CAD 0.04

(-12.5%)

Gross Profit Summary of Appili Therapeutics Inc.

Appili Therapeutics Inc.'s latest annual gross profit in 2023 was 813.74 Thousand CAD , up 148.16% from previous year.
Appili Therapeutics Inc.'s latest quarterly gross profit in 2024 Q1 was -3365.00 CAD , down -139.69% from previous quarter.
Appili Therapeutics Inc. reported a annual gross profit of 327.91 Thousand CAD in annual gross profit 2022, down -76.42% from previous year.
Appili Therapeutics Inc. reported a annual gross profit of 1.39 Million CAD in annual gross profit 2021, up 9473.71% from previous year.
Appili Therapeutics Inc. reported a quarterly gross profit of 8478.00 CAD for 2023 Q4, down -98.22% from previous quarter.
Appili Therapeutics Inc. reported a quarterly gross profit of 813.74 Thousand CAD for 2023 FY, up 148.16% from previous quarter.

Annual Gross Profit Chart of Appili Therapeutics Inc. (2023 - 2016)

Historical Annual Gross Profit of Appili Therapeutics Inc. (2023 - 2016)

Year	Gross Profit	Gross Profit Growth
2023	813.74 Thousand CAD	148.16%
2022	327.91 Thousand CAD	-76.42%
2021	1.39 Million CAD	9473.71%
2020	-14.83 Thousand CAD	-107.45%
2019	199.1 Thousand CAD	1061.21%
2018	-20.71 Thousand CAD	-17.23%
2017	-17.67 Thousand CAD	-68.21%
2016	-10.5 Thousand CAD	0.0%

Year	Gross Profit	Gross Profit Growth
2024 Q1	-3365.00 CAD	-139.69%
2023 Q4	8478.00 CAD	-98.22%
2023 FY	813.74 Thousand CAD	148.16%
2023 Q3	475 Thousand CAD	42.27%
2023 Q2	333.87 Thousand CAD	9799.91%
2023 Q1	-3442.00 CAD	-101.04%
2022 Q1	-1549.00 CAD	50.32%
2022 Q4	332.55 Thousand CAD	21596.57%
2022 FY	327.91 Thousand CAD	-76.42%
2022 Q3	-1547.00 CAD	-0.06%
2022 Q2	-1546.00 CAD	0.19%
2021 Q3	1.39 Million CAD	43369.57%
2021 FY	1.39 Million CAD	9473.71%
2021 Q1	-3111.00 CAD	17.74%
2021 Q2	-3214.00 CAD	-3.31%
2021 Q4	-3118.00 CAD	-100.22%
2020 FY	-14.83 Thousand CAD	-107.45%
2020 Q1	- CAD	0.0%
2020 Q4	-3782.00 CAD	0.0%
2020 Q3	- CAD	0.0%
2020 Q2	- CAD	0.0%
2019 Q3	199.1 Thousand CAD	0.0%
2019 Q2	- CAD	0.0%
2019 Q1	- CAD	0.0%
2019 FY	199.1 Thousand CAD	1061.21%
2019 Q4	- CAD	-100.0%
2018 FY	-20.71 Thousand CAD	-17.23%
2018 Q4	- CAD	0.0%
2018 Q1	- CAD	0.0%
2018 Q2	- CAD	0.0%
2018 Q3	- CAD	0.0%
2017 FY	-17.67 Thousand CAD	-68.21%
2017 Q4	- CAD	0.0%
2017 Q3	- CAD	0.0%
2016 FY	-10.5 Thousand CAD	0.0%

Peer Gross Profit Comparison of Appili Therapeutics Inc.

Name	Gross Profit	Gross Profit Difference
Eupraxia Pharmaceuticals Inc.	-209.91 Thousand CAD	487.662%
Helix BioPharma Corp.	-14 Thousand CAD	5912.464%
Microbix Biosystems Inc.	7.48 Million CAD	89.123%
Medicenna Therapeutics Corp.	-5000.00 CAD	16374.9%
Satellos Bioscience Inc.	-8.81 Million CAD	109.229%
Oncolytics Biotech Inc.	-403 Thousand CAD	301.922%
Sernova Corp.	-445.55 Thousand CAD	282.638%